BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12263338)

  • 21. Detection of beta subunit HCG in plasma of IUD users as an indication of frequency of conception.
    Nilsson CG; Lähteenmäki P; Luukkainen T
    Int J Fertil; 1979; 24(2):134-7. PubMed ID: 40908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corpus luteum function in lactating women using the Progestasert system.
    Abdalla MI; Ibrahim II; Osman MI; Badraoui MH; Askalani H
    Contracept Deliv Syst; 1981 Apr; 2(1):127-32. PubMed ID: 12336864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential control of fertility in women by immunization with HCG.
    Stevens VC
    Res Reprod; 1975 May; 7(3):1-2. PubMed ID: 12258419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Demonstration of human chorionic gonadotropin during the second half of the menstrual cycle in plasma of regularly menstruating women users of copper IUds.
    Capitanio GL; Conte N; Ragni N; Rossato P; Pedretti E
    Acta Eur Fertil; 1978 Mar; 9(1):11-9. PubMed ID: 696185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Endocrine and psychological problems in women subjected to tubal sterilization].
    Cappa F; Mascaretti G; Barchiesi S; Iagnemma G; Barbati D; Marinacci S; Pozzi V
    Patol Clin Ostet Ginecol; 1984; 12(3):209-13. PubMed ID: 12267497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Production of human chorionic gonadotropin during the normal menstrual cycle.
    Cole LA; Gutierrez JM
    J Reprod Med; 2009 Apr; 54(4):245-50. PubMed ID: 19438167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progress in immunological fertility control.
    Thanavala Y
    IPPF Med Bull; 1981 Jun; 15(3):2-3. PubMed ID: 12278629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pregnancy vaccine research.
    Talwar GP
    Netw Res Triangle Park N C; 1985; 6(2):7-8. PubMed ID: 12266649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An explanation of the mechanism of preventing pregnancy by IUCD.
    Blum M; Ariel J; Pery J
    Br J Sex Med; 1983 Oct; 10(10):30-2. PubMed ID: 12265802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cycle abnormalities and secondary sterility after estrogen-gestagen treatment].
    Gigon U; Zarro D; Stamm O
    Schweiz Z Gynakol Geburtshilfe; 1972; 3(2):133-40. PubMed ID: 12333145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pituitary reserve for gonadotrophins and prolactin in women under long-term use of depo-medroxyprogesterone acetate (DMPA) as a contraceptive.
    Mukasa FR; Sekadde-kigondu CB; Mati JK; Njoroge JK
    J Obstet Gynaecol East Cent Africa; 1982 Dec; 1(4):160-3. PubMed ID: 12313677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The measurement of human chorionic gonadotropin for pregnancy testing.
    Feldkamp CS; Pfeffer WH
    Henry Ford Hosp Med J; 1982; 30(4):207-13. PubMed ID: 7169378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormonal characteristics in the early luteal phase of conceptive and nonconceptive menstrual cycles.
    Chen J; Qiu Q; Lohstroh PN; Overstreet JW; Lasley BL
    J Soc Gynecol Investig; 2003 Jan; 10(1):27-31. PubMed ID: 12517590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immuno-contraception undergoing promising trials.
    Koshy LM
    Indian Med Trib; 1994 Aug; 2(13):7. PubMed ID: 12179186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value of subcutaneous fat in predicting ovulation day.
    Jamaludin J; Nordin NM; Mohamad N; Etta KM
    Malays J Reprod Health; 1988 Jun; 6(1):65-9. PubMed ID: 12281593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endocrine modifications associated with final oocyte maturation with gonadotropin-releasing hormone agonists vs. human chorionic gonadotropin in women undergoing intrauterine insemination.
    Díaz I; Guillén A; Pacheco A; Requena A; Garcia-Velasco JA
    J Reprod Med; 2008 Jan; 53(1):33-9. PubMed ID: 18251359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New studies link IUDs, infertility; say copper devices safer.
    Contracept Technol Update; 1985 Jun; 6(6):81-3. PubMed ID: 12313655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absence of hCG-like activity in the blood of women fitted with intra-uterine contraceptive devices.
    Sharpe RM; Wrixon W; Hobson BM; Corker CS; McLean HA; Short RV
    J Clin Endocrinol Metab; 1977 Sep; 45(3):496-9. PubMed ID: 903400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Contraception with pure, synthetic progestogens of the norpregnane group, a new approach for the future?].
    Rozenbaum H
    Contracept Fertil Sex (Paris); 1986 Jun; 14(6):577-81. PubMed ID: 12341096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whither an anti-hCG approach for the control of fertility.
    Res Reprod; 1981 Jul; 13(3):1-2. PubMed ID: 12263408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.